Table 10.

Post hoc test showing requirement of mean antipsychotic (chlorpromazine equivalent) dose and Cassidy Scale for Manic States change from baseline to end of the study using multiple comparison across the three treatment groups

Dependent variable	Multiple comparison		Mean difference	P	95% CI
	Treatment group	Treatment group			Lower bound	Upper bound
Mean antipsychotic (CPZ equivalent)	Lithium	Carbamazepine	−87.50	0.014	−156.37	−18.62
		Sodium valproate	−75.41	0.042	−147.84	−2.99
	Carbamazepine	Lithium	87.50	0.014	18.62	156.37
		Sodium valproate	12.08	0.760	−66.61	90.78
	Sodium valproate	Lithium	75.41	0.042	2.99	147.84
		Carbamazepine	−12.08	0.760	−90.78	66.61
CSMS change from baseline to end of the study	Lithium	Carbamazepine	12.52	0.137	−4.11	29.16
		Sodium valproate	−5.80	0.510	−23.30	11.69
	Carbamazepine	Lithium	−12.52	0.137	−29.16	4.11
		Sodium valproate	−18.32	0.059	−37.34	0.68
	Sodium valproate	Lithium	5.80	0.510	−11.69	23.30
		Carbamazepine	18.32	0.059	−0.68	37.34

P<0.05. CI – Confidence interval; CPZ – Chlorpromazine; CSMS – Cassidy Scale for Manic States